A detailed history of Van Eck Associates Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Van Eck Associates Corp holds 1,875,387 shares of TEVA stock, worth $34.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,875,387
Previous 1,666,714 12.52%
Holding current value
$34.9 Million
Previous $27.1 Million 27.48%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$15.81 - $18.96 $3.3 Million - $3.96 Million
208,673 Added 12.52%
1,875,387 $34.5 Million
Q2 2024

Jul 31, 2024

BUY
$12.78 - $17.4 $1.53 Million - $2.08 Million
119,730 Added 7.74%
1,666,714 $27.1 Million
Q1 2024

Apr 30, 2024

SELL
$10.67 - $14.43 $4.22 Million - $5.71 Million
-395,458 Reduced 20.36%
1,546,984 $21.8 Million
Q4 2023

Feb 05, 2024

SELL
$8.12 - $10.63 $2.63 Million - $3.44 Million
-323,647 Reduced 14.28%
1,942,442 $20.3 Million
Q3 2023

Nov 08, 2023

SELL
$7.48 - $10.7 $2.25 Million - $3.21 Million
-300,333 Reduced 11.7%
2,266,089 $23.1 Million
Q2 2023

Aug 03, 2023

BUY
$7.2 - $9.47 $6.43 Million - $8.45 Million
892,702 Added 53.34%
2,566,422 $19.3 Million
Q1 2023

May 03, 2023

SELL
$8.36 - $11.37 $8.1 Million - $11 Million
-969,380 Reduced 36.68%
1,673,720 $14.8 Million
Q4 2022

Feb 08, 2023

BUY
$7.95 - $9.48 $2.77 Million - $3.31 Million
348,658 Added 15.2%
2,643,100 $24.1 Million
Q3 2022

Oct 27, 2022

SELL
$6.86 - $11.95 $6.31 Million - $11 Million
-919,292 Reduced 28.61%
2,294,442 $18.5 Million
Q2 2022

Aug 03, 2022

BUY
$7.38 - $10.4 $9.78 Million - $13.8 Million
1,324,951 Added 70.15%
3,213,734 $24.2 Million
Q1 2022

May 10, 2022

SELL
$7.33 - $9.39 $172,570 - $221,068
-23,543 Reduced 1.23%
1,888,783 $17.7 Million
Q4 2021

Jan 26, 2022

BUY
$7.9 - $10.19 $2.41 Million - $3.11 Million
305,004 Added 18.98%
1,912,326 $15.3 Million
Q3 2021

Nov 03, 2021

BUY
$8.38 - $10.18 $3.27 Million - $3.97 Million
390,180 Added 32.06%
1,607,322 $15.7 Million
Q2 2021

Aug 10, 2021

BUY
$9.9 - $11.56 $4 Million - $4.68 Million
404,483 Added 49.77%
1,217,142 $12.1 Million
Q1 2021

May 13, 2021

SELL
$10.34 - $12.81 $2.6 Million - $3.22 Million
-251,624 Reduced 23.64%
812,659 $9.38 Million
Q4 2020

Feb 09, 2021

SELL
$8.61 - $11.04 $1.15 Million - $1.47 Million
-133,002 Reduced 11.11%
1,064,283 $10.3 Million
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $2.71 Million - $4.01 Million
316,201 Added 35.89%
1,197,285 $10.8 Million
Q2 2020

Aug 10, 2020

SELL
$8.12 - $13.12 $389,841 - $629,891
-48,010 Reduced 5.17%
881,084 $10.9 Million
Q1 2020

May 12, 2020

BUY
$6.69 - $13.45 $276,089 - $555,068
41,269 Added 4.65%
929,094 $8.34 Million
Q4 2019

Feb 13, 2020

BUY
$6.53 - $10.72 $1.37 Million - $2.26 Million
210,525 Added 31.08%
887,825 $8.7 Million
Q3 2019

Nov 08, 2019

SELL
$6.16 - $9.6 $1.3 Million - $2.02 Million
-210,457 Reduced 23.71%
677,300 $4.66 Million
Q2 2019

Aug 07, 2019

BUY
$8.12 - $15.72 $2.87 Million - $5.55 Million
352,843 Added 65.96%
887,757 $8.19 Million
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $1.03 Million - $1.32 Million
-66,001 Reduced 10.98%
534,914 $8.39 Million
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $647,051 - $1.06 Million
44,349 Added 7.97%
600,915 $9.27 Million
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $646,078 - $786,890
-30,678 Reduced 5.22%
556,566 $12 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $240,968 - $355,057
-14,369 Reduced 2.39%
587,244 $14.3 Million
Q1 2018

May 11, 2018

SELL
$16.68 - $22.07 $4.26 Million - $5.64 Million
-255,485 Reduced 29.81%
601,613 $10.3 Million
Q4 2017

Feb 12, 2018

BUY
$11.23 - $19.1 $558,995 - $950,740
49,777 Added 6.17%
857,098 $16.2 Million
Q3 2017

Nov 09, 2017

BUY
$15.41 - $32.17 $5.71 Million - $11.9 Million
370,380 Added 84.77%
807,321 $14.2 Million
Q2 2017

Aug 11, 2017

BUY
N/A
436,941
436,941 $14.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $20.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.